Yusein-Myashkova Shazie, Ugrinova Iva, Pasheva Evdokia
Institute of Molecular Biology, Roumen Tsanev, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria.
BMB Rep. 2016 Feb;49(2):99-104. doi: 10.5483/bmbrep.2016.49.2.238.
The nuclear non-histone protein high mobility group box (HMGB) 1 is known to having an inhibitory effect on the repair of DNA damaged by the antitumor drug cisplatin in vitro. To investigate the role of HMGB1 in living cells, we studied the DNA repair of cisplatin damages in mouse fibroblast cell line, NIH-3T3. We evaluated the effect of the post-synthetic acetylation and C-terminal domain of the protein by overexpression of the parental and mutant GFP fused forms of HMGB1. The results revealed that HMGB1 had also an inhibitory effect on the repair of cisplatin damaged DNA in vivo. The silencing of HMGB1 in NIH-3T3 cells increased the cellular DNA repair potential. The increased levels of repair synthesis could be "rescued" and returned to less than normal levels if the knockdown cells were transfected with plasmids encoding HMGB1 and HMGB1 K2A. In this case, the truncated form of HMGB1 also exhibited a slight inhibitory effect. [BMB Reports 2016; 49(2): 99-104].
已知核非组蛋白高迁移率族盒(HMGB)1在体外对由抗肿瘤药物顺铂损伤的DNA修复具有抑制作用。为了研究HMGB1在活细胞中的作用,我们在小鼠成纤维细胞系NIH-3T3中研究了顺铂损伤的DNA修复。我们通过过表达亲本和突变型绿色荧光蛋白(GFP)融合形式的HMGB1来评估该蛋白合成后乙酰化和C末端结构域的作用。结果显示,HMGB1在体内对顺铂损伤的DNA修复也具有抑制作用。在NIH-3T3细胞中沉默HMGB1可提高细胞的DNA修复潜能。如果用编码HMGB1和HMGB1 K2A的质粒转染敲低细胞,修复合成水平的增加可以被“挽救”并恢复到低于正常水平。在这种情况下,截短形式的HMGB1也表现出轻微的抑制作用。[《BMB报告》2016年;49(2):99 - 104]